As of 2026-01-05, the Relative Valuation of Chinook Therapeutics Inc (KDNY) is (41.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.39 USD, the upside of Chinook Therapeutics Inc based on Relative Valuation is -204.0%.
The range of the Relative Valuation is (30.45) - (53.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 15.6x | 12.2x |
| Forward P/E multiples | 8.9x - 15.8x | 12.4x |
| Fair Price | (30.45) - (53.23) | (41.99) |
| Upside | -175.4% - -231.8% | -204.0% |
| Date | P/E |